福島県立医科大学 · 放射線腫瘍学講座 · 准教授

研究キーワードrenal cell carcinoma・endoscopic combined intrarenal surgery・immune checkpoint inhibitors・nivolumab plus ipilimumab・immune-related adverse events・fukushima daiichi nuclear power plant

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Combination of oligo-fractionated irradiation with nivolumab can induce immune modulation in gastric cancer.2024 · Mimura K, Ogata T, Nguyen PHD, Roy S, Kared H, Yuan YC, Fehlings M, Yoshimoto Y, Yoshida D, Nakajima S, Sato H, Machida N, Yamada T, Watanabe Y, Tamaki T, Fujikawa H, Inokuchi Y, Hayase S, Hanayama H, Saze Z, Katoh H, Takahashi F, Oshima T, Goel A, Nardin A, Suzuki Y, Kono K
• Anti-PD-1 monoclonal antibody-resistant esophageal squamous cell carcinoma showing the abscopal effect: A case report with T-cell receptor/B-cell receptor repertoire analysis.2023 · Takehara Y, Mimura K, Suzuki Y, Watanabe Y, Yoshimoto Y, Saze Z, Sato H, Tamaki T, Kono K
• Disaster Resilience Reduces Radiation-Related Anxiety Among Affected People 10 Years After the Fukushima Daiichi Nuclear Power Plant Accident.2022 · Kobayashi T, Maeda M, Nakayama C, Takebayashi Y, Sato H, Setou N, Momoi M, Horikoshi N, Yasumura S, Ohto H
• Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.2022 · Ikeda M, Suzuki M, Matsuzuka T, Ishii S, Sato H, Murono S

• 公式プロフィール